New plasma components.
D000799:Angioedema / Q000628:therapy; D000990:Antithrombin III / Q000627:therapeutic use; D020152:Antithrombin III Deficiency; D001792:Blood Platelets / Q000378:metabolism; D001798:Blood Proteins / Q000627:therapeutic use*; D001803:Blood Transfusion; D002448:Cell Adhesion; D055598:Chemical Phenomena; D002621:Chemistry; D003174:Complement C1 Inactivator Proteins / Q000627:therapeutic use; D005260:Female; D005353:Fibronectins / Q000097:blood / Q000172:deficiency / Q000502:physiology / Q000627:therapeutic use; D006487:Hemostasis; D006801:Humans; D010587:Phagocytosis; D010949:Plasma / Q000032:analysis*; D011247:Pregnancy; D000515:alpha 1-Antitrypsin / Q000627:therapeutic use
D001798:Blood Proteins; D003174:Complement C1 Inactivator Proteins; D005353:Fibronectins; D000515:alpha 1-Antitrypsin; D000990:Antithrombin III